Package 58118-8005-8

{"route": ["SUBLINGUAL"], "spl_id": "0e89609b-bd43-291f-e063-6294a90a623e", "openfda": {"unii": ["5Q187997EE", "56W8MW3EN1"], "rxcui": ["351266", "351267"], "spl_set_id": ["273b79ac-2c62-4407-9cd1-2a2964ef13ba"], "manufacturer_name": ["Clinical Solutions Wholesale, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BLISTER PACK (58118-8005-8)", "package_ndc": "58118-8005-8", "marketing_start_date": "20230711"}], "brand_name": "Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate", "product_id": "58118-8005_0e89609b-bd43-291f-e063-6294a90a623e", "dosage_form": "TABLET", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]", "Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "58118-8005", "dea_schedule": "CIII", "generic_name": "Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate", "labeler_name": "Clinical Solutions Wholesale, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": "2 mg/1"}, {"name": "NALOXONE HYDROCHLORIDE DIHYDRATE", "strength": ".5 mg/1"}], "application_number": "ANDA207000", "marketing_category": "ANDA", "marketing_start_date": "20171213", "listing_expiration_date": "20261231"}